Abstract

The 2009 influenza pandemic, the variant H3N2v viruses in agricultural fairs and the zoonotic poultry H5N9 infections in China have highlighted the constant threat that influenza A viruses (IAV) present to people and animals. In this study we evaluated the effect of IAV vaccination on aerosol shedding in pigs housed in warm environmental conditions. Thirty-six, three-week old weaned pigs were obtained from an IAV negative herd and were randomly allocated to one of 4 groups: 1) a homologous vaccine group, 2) a heterologous multivalent vaccine group, 3) a heterologous monovalent group and, 4) a non-vaccinated group. After vaccination pigs were challenged with the triple reassortant A/Sw/IA/00239/04 H1N1 virus. Environmental temperature and relative humidity were recorded throughout the study. Nasal swabs, oral fluids and air samples were collected daily. All samples were tested by RRT-PCR and virus isolation was attempted on positive samples. Average temperature and relative humidity throughout the study were 27°C (80°F) and 53%, respectively. A significantly higher proportion of infected pigs was detected in the non-vaccinated than in the vaccinated group. Lower levels of nasal virus shedding were found in vaccinated groups compared to non-vaccinated group and IAV was not detected in air samples of any of the vaccinated groups. In contrast, positive air samples were detected in the non-vaccinated group at 1, 2 and 3 days post infection although the overall levels were considered low most likely due to the elevated environmental temperature. In conclusion, both the decrease in shedding and the increase in environmental temperature may have contributed to the inability to detect airborne IAV in vaccinated pigs.

Highlights

  • Influenza A virus (IAV) is a negative sense single stranded RNA virus belonging to the Orthomyxoviridae family

  • Pigs were randomly assigned to one of four experimental groups: a) group 1 (VAC-HOM), pigs were vaccinated with a homologous vaccine (Newport Labs, Worthington, MN) to the A/Sw/IA/00239/04 (H1N1 beta clade 1A.2) challenge virus; b) group 2 (VAC-HET MULTI) pigs were vaccinated with a commercial heterologous multivalent vaccine, containing A/Sw/NC/031/05 (H1N1 delta2 clade 1B.2.1), A/Sw/MO/069/05 (H3N2 Cluster IV) and A/ Sw/IA/110600/00 (H1N1 gamma2 clade 1A.3.2) IAV strains (FluSure XP1, Zoetis, New York, NY); c) group 3 (VAC-HET MONO) pigs were vaccinated with a commercial heterologous monovalent vaccine, containing A/CA/04/2009 (H1N1 npdm clade 1A.3.3.2) (Flusure1 Pandemic, Zoetis, New York, NY) and d) group 4 (NON-VAC) pigs were vaccinated with a sterile

  • Pigs in the VAC-HET MULTI group were further tested by hemagglutination inhibition (HI) against the IAV strains contained in the commercial multivalent vaccine and tested positive (S1 Table)

Read more

Summary

Introduction

Influenza A virus (IAV) is a negative sense single stranded RNA virus belonging to the Orthomyxoviridae family. IAV affects people and many animal species including pigs. Pigs play an important role in the ecology of IAV infections. Pigs can serve as mixing vessels resulting in the generation of novel IAVs [4], and serve as reservoirs for strains of zoonotic and pandemic potential [5,6,7]. The 2009 H1N1 pandemic and the H3N2 variant events in agricultural fairs have highlighted the risk of IAV transmission from pigs to humans and vice-versa making understanding transmission routes a priority [11,12,13]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.